과제정보
연구 과제 주관 기관 : 일성신약
참고문헌
- Klugman KP, Koornhof HJ. Drug resistance patterns and serogroups or serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 1979-1986. J Infect Dis 1988;158:956-64 https://doi.org/10.1093/infdis/158.5.956
- Soh SW, Poh CL, Pin Lin RVT. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from pediatric patients in Singarpore. Antimicobial Agents Chemother 2000;44:2193-6 https://doi.org/10.1128/AAC.44.8.2193-2196.2000
- Charpentier E, Tuomanen E. Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. Microbes Infect 2000;2:1855-64 https://doi.org/10.1016/S1286-4579(00)01345-9
- Felmingham D, Washington J. The Alexander Project Group. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens. Findings of the Alexander Project 1992-1996. J Chemother 1999;11:5-21
- Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically approved standard(ed 6). NCCLS document M7-6. Wayne, Pa : National Committee for Clinical Laboratory Standards, 2003
- Finch R. Bacterial resistance : the clinical challenge. Clin Microbiol Infect 2002;8 Suppl 3:21S-32S https://doi.org/10.1046/j.1469-0691.8.s.3.3.x
- Calvo A, Amores R, Valero E, Sevillano D, Prieto J. Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae. Rev Esp Quimioter 2001;14:345-50
- Cunha BA. Penicillin resistance in pneumococcal pneumonia. Postgrad Med 2003;113:42-54
- Hakenbeck R, Grebe T, Zahner D, Stock JB. Beta lactam resistance in Streptococcus pneumoniae : penicillin-binding proteins and non-penicillin-binding proteins. Mol Microbiol 1999;33:673-8 https://doi.org/10.1046/j.1365-2958.1999.01521.x
- Grebe T, Hakenbeck R. Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics. Antimicro Agents Chemother 1996;40:829-34
- Bauer T, Ewig S, Marcos MA, Schultze W, Torres A. Streptococcus pneumoniae in community acquired pneumonia. How important is drug resistance? Med Clin North Am 2001;85:1367-79 https://doi.org/10.1016/S0025-7125(05)70385-0
- Spika JS, Facklam RR, Plikaytis BD, Oxtoby MJ. Pneumococcal surveillance working group. Antimicrobial resistance of Streptococcus pneumoniae in the Unites States : 1979-1987. J Infect Dis 1991;163:1273-8 https://doi.org/10.1093/infdis/163.6.1273
- Jackson MA, Shelton S, Nelson JD, McCracken GH. Relatively penicillin-resistant pneumococcal infections in pediatric patients. Pediatr Infect Dis 1984;3:129-84 https://doi.org/10.1097/00006454-198403000-00010
- Goldstein FW, Acar JF. Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 Western Europe and USA collaborative surveillance study. J Antimicrob Chemother 1996;38: 71-8 https://doi.org/10.1093/jac/38.suppl_A.71
- McCracker GH Jr. Emergence of resistant Streptococcus pneumoniae : a problem in pediatrics. Pediatr Infect Dis 1995;14:424-8 https://doi.org/10.1097/00006454-199505001-00004
- Chesney PJ. The escalating problem of antimicrobial resistance in Streptococcus Pneumoniae. Am J Dis Child 1992;146:912-6
- Gray BM, Converse GM III, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants : acquisition, carriage, and infection during the first 24 months of life. Infect Dis 1980;142:923-33 https://doi.org/10.1093/infdis/142.6.923
- Reichler MR, Allphin AA, Breiman RF. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992;166:1346-53 https://doi.org/10.1093/infdis/166.6.1346
- McCracker GH Jr. Emergence of resistant Streptococcus pneumoniae : a problem in pediatrics. Pediatr Infect Dis 1995;14:424-8 https://doi.org/10.1097/00006454-199505001-00004
- Klugman KP. The clinical relevance of in-vitro resistance penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus Influenzae and Moraxella catarrhalis. J Antimicrob Chemother 1996;38 Suppl A:133S-40S
- Goldstein FW, Acar JF. Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae : results of a 1992-93 Western Europe and USA collaborative surveillance study. J Antimicrob Chemother 1996;38:71-84 https://doi.org/10.1093/jac/38.suppl_A.71
- Goldstein FW. Choice of an oral beta-lactam antibiotic for infections due to penicillin resistant Streptococcus pneumoniae. Scan J Infect Dis 1997;29:255-7 https://doi.org/10.3109/00365549709019038
- Christine ET, Sarah JK and David IE. In vitro activities of oral beta-lactams at concentrations achived in humans against penicillin-susceptible and resistant pneumococci and potential to select resistance. Antimicrob Agents Chemther 1998;42:1973-6
- Alves G. Sensitivity of pneumococcus to antibiotics and the treatment pneumonia in children. J Pediatr 2003;79:95-6
- Heffelfinger JD, Dowell SF, Jorensen JH, Klugman K, Marby LR, Musher DM, et al. Management of community acquired pneumonia in the era of pneumococcal resistance. A report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med 2000;160: 1399-408 https://doi.org/10.1001/archinte.160.10.1399
- Klugman KP. Bacteriologic evidence of antibiotic failure in pneumococcal lower respiratory infections. Eur Resp J 2002; 20(36 Suppl):3S-8S
- Craig WA. Pharmacokinetic/pharmacodynamic parameters : rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1-12 https://doi.org/10.1086/516284
- Jacobs MR. Optimization of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin Microbiol Infect 2001;7:589-96 https://doi.org/10.1046/j.1198-743x.2001.00295.x
- Dusano GL, Craig WA. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. J Chemother 1997;9(13 Suppl):38S- 44S
- Byran CS, Talwani R, Stinson MS. Penicillin dosing for pneumococcal pneumonia. Chest 1997;112:1657-64 https://doi.org/10.1378/chest.112.6.1657
- Friedland IR. Comparison of the response to antimicrobial therapy of penicillin resistant and penicillin susceptibile pneumococcal disease. Pediatr Infect Dis J 1995;14:885-90 https://doi.org/10.1097/00006454-199510000-00013
- Falconi FQ, Calva JJ, Vidal YL, Velazo MG, Martinez MEZ and Mondragon LL. Antimicrobial susceptibility patterns of Streptococcus pneumoniae in Mexico. Dia Micro and Infect Dis 2004;49:53-8 https://doi.org/10.1016/j.diagmicrobio.2004.02.001
- Tan TQ, Mason Jr EO, Barson WJ, Wald ER, Schutze GE, Bradly JS, et al. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics 1998;102:1369-75 https://doi.org/10.1542/peds.102.6.1369
- Feldman C. Clinical relevance of antimicrobial resistance in the management of pneumococcal community -acquired pneumonia. J Lab and Clin Med 2004;143:269-83 https://doi.org/10.1016/j.lab.2004.02.002
- Severin AE, Severina, A Tomasz. Abnormal physiological properties and altered cell wall composition in Streptococcus pneumoniae grown in the presence of clavulanic acid. Antimicrob Agents Chemother 1997;41:504-10
- Nelson CT, Mason EO Jr, Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin resistant Streptococcus pneumoniae : implications for treatment. Pediatr Infect Dis J 1994;13:585-9 https://doi.org/10.1097/00006454-199407000-00001
- Ailani RK, Alimchandani A, Hidalgo J, Ailani R, Buckley J, DiGiovine B. Cephalosporin-resistant pneumococcal pneumonia : does it affect outcome? Respir Med 2002;96:805-11 https://doi.org/10.1053/rmed.2002.1358